FTO-mediated LINC01134 stabilization to promote chemoresistance through miR-140-3p/WNT5A/WNT pathway in PDAC
出版年份 2023 全文链接
标题
FTO-mediated LINC01134 stabilization to promote chemoresistance through miR-140-3p/WNT5A/WNT pathway in PDAC
作者
关键词
-
出版物
Cell Death & Disease
Volume 14, Issue 11, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-01
DOI
10.1038/s41419-023-06244-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- m6A-enriched lncRNA LINC00839 promotes tumor progression by enhancing TAF15-mediated transcription of amine oxidase AOC1 in nasopharyngeal carcinoma
- (2023) Wei-Hong Zheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis
- (2023) Ke Li et al. Journal of Translational Medicine
- m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p
- (2023) Li Qi et al. Genes & Genomics
- Epigenetic modification of m6A regulator proteins in cancer
- (2023) Yumin Wang et al. Molecular Cancer
- M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription
- (2023) Jinbo Xie et al. ONCOGENE
- LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3
- (2021) Gege Shu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The emerging roles of RNA m6A methylation and demethylation as critical regulators of tumorigenesis, drug sensitivity, and resistance
- (2021) Qing Lan et al. CANCER RESEARCH
- LSD1‐Demethylated LINC01134 Confers Oxaliplatin Resistance via SP1‐induced p62 Transcription in Hepatocellular Carcinoma
- (2021) Luyuan Ma et al. HEPATOLOGY
- Pancreatic Cancer
- (2021) Wungki Park et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2
- (2021) Guizhi Jia et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Molecular interplay between linc01134 and YY1 dictates hepatocellular carcinoma progression
- (2020) Zhonghou Rong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer
- (2020) Honglei Wu et al. Cell Death & Disease
- LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway
- (2020) Liping Wu et al. Cancer Cell International
- The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression
- (2020) Chao Tu et al. CELL PROLIFERATION
- Long Noncoding RNA LINC01134 Promotes Hepatocellular Carcinoma Metastasis via Activating AKT1S1 and NF-κB Signaling
- (2020) Chao Wang et al. Frontiers in Cell and Developmental Biology
- LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p
- (2020) Baiqi Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Nanotechnology improves the therapeutic efficacy of gemcitabine against a human hepatocellular carcinoma cell line and minimizes its in vivo side effects
- (2020) Sawsan M. A. El-Sheikh et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- lncRNA LCPAT1 Upregulation Promotes Breast Cancer Progression via Enhancing MFAP2 Transcription
- (2020) Xue Gong et al. Molecular Therapy-Nucleic Acids
- Gene regulation by long non-coding RNAs and its biological functions
- (2020) Luisa Statello et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Salinomycin exerts anti‐colorectal cancer activity by targeting the β‐catenin/T‐cell factor complex
- (2019) Zhongyuan Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer
- (2019) Hengqiang Zhao et al. Molecular Therapy-Oncolytics
- Long noncoding RNA SOX2OT promotes the proliferation of pancreatic cancer by binding to FUS
- (2019) Lei Chen et al. INTERNATIONAL JOURNAL OF CANCER
- USP20 positively regulates tumorigenesis and chemoresistance through β-catenin stabilization
- (2018) Chenming Wu et al. CELL DEATH AND DIFFERENTIATION
- RNA N6-methyladenosine modification in cancers: current status and perspectives
- (2018) Xiaolan Deng et al. CELL RESEARCH
- LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363
- (2018) Hai Huang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling
- (2018) Srijayaprakash Babu Uppada et al. Molecular Cancer
- The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling
- (2017) Peng Han et al. Molecular Cancer
- Salinomycin: A new paradigm in cancer therapy
- (2017) Jayant Dewangan et al. TUMOR BIOLOGY
- Pancreatic Cancer Chemoresistance to Gemcitabine
- (2017) Manoj Amrutkar et al. Cancers
- Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
- (2016) Le Qu et al. CANCER CELL
- YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4–NOT deadenylase complex
- (2016) Hao Du et al. Nature Communications
- Long non-coding RNAs in anti-cancer drug resistance
- (2016) Qin-nan Chen et al. Oncotarget
- The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1
- (2015) Lufeng Zheng et al. BREAST CANCER RESEARCH AND TREATMENT
- The emerging role of lncRNAs in cancer
- (2015) Maite Huarte NATURE MEDICINE
- Current status and progress of pancreatic cancer in China
- (2015) Quan-Jun Lin WORLD JOURNAL OF GASTROENTEROLOGY
- Long noncoding RNAs: a potential novel class of cancer biomarkers
- (2015) Aliaksandr A. Yarmishyn et al. Frontiers in Genetics
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Salinomycin Suppresses LRP6 Expression and Inhibits Both Wnt/β-catenin and mTORC1 Signaling in Breast and Prostate Cancer Cells
- (2014) Wenyan Lu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The multilayered complexity of ceRNA crosstalk and competition
- (2014) Yvonne Tay et al. NATURE
- Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway
- (2012) Hui Zhang et al. CANCER LETTERS
- Harnessing gemcitabine metabolism: a step towards personalized medicine for pancreatic cancer
- (2012) Muhammad Wasif Saif et al. Therapeutic Advances in Medical Oncology
- N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
- (2011) Guifang Jia et al. Nature Chemical Biology
- Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells
- (2011) Desheng Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
- (2010) Sonja Gillen et al. PLOS MEDICINE
- Evolution and Functions of Long Noncoding RNAs
- (2009) Chris P. Ponting et al. CELL
- Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players
- (2008) M. P. Kim et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started